Infections of neonatal and adult mice with murine CMV HaNa1 strain upon oronasal inoculation: New insights in the pathogenesis of natural primary CMV infections

Virus Research

Volumn 211, Issue , 2016, Pages 96-102

  Xiang, Jun ^a   Zhang, Shunchuan ^a   Nauwynck, Hans ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Adult; Murine cytomegalovirus; Natural primary infection; Neonatal; Nose; Oronasally

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; INOCULATION; LYMPHOID TISSUE; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; NOSE MUCOSA; OLFACTORY EPITHELIUM; PRIORITY JOURNAL; SUBMANDIBULAR GLAND; VIRUS DETECTION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; ANIMAL STRUCTURES; BAGG ALBINO MOUSE; CYTOMEGALOVIRUS; DISEASE MODEL; FEMALE; GENETICS; HUMAN; MALE; NOSE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMAL STRUCTURES; ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; NOSE; VIRULENCE; VIRUS REPLICATION;

EID: 84951733449     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.10.010     Document Type: Article

References (32)

1. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 2004, 4(7):553-564.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296(5571):1323-1326.
3. Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., Yamanishi K. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, Cambridge University Press.
4. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 1996, 26(7):1489-1496.
5. Berger C., Hug M., Gysin C., Molinari L., Frei M., Bossart W., Nadal D. Distribution patterns of beta- and gamma-herpesviruses within Waldeyer's ring organs. J. Med. Virol. 2007, 79(8):1147-1152.
6. Britt W. Human cytomegalovirus infections and mechanisms of disease. Cytomegalovirus: Molecular Biology and Immunology 2006, 1-28. Caister Academic Press, Norfolk. M.J. Reddehase (Ed.).
7. Chan B.W., Woo J.K., Liew C.T. Cytomegalovirus infection of the nasopharynx. J. Clin. Pathol. 2002, 55(12):970-972.
8. Cretney E., Degli-Esposti M.A., Densley E.H., Farrell H.E., Davis-Poynter N.J., Smyth M.J. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 1999, 190(3):435-444.
9. David D., Ravid Z., Morag A. Detection of human cytomegalovirus DNA in human tonsillar lymphocytes. J. Med. Virol. 1987, 23(4):383-391.
10. Hayashi K., Eizuru Y., Sato S., Minamishima Y. The role of NK cell activity in age-dependent resistance of mice to murine cytomegalovirus infection. Microbiol. Immunol. 1985, 29(10):939-950.
11. Hudson J.B. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch. Virol. 1979, 62(1):1-29.
12. Hudson J.B. Mouse cytomegalovirus (murid herpesvirus 1). Virus Infections of Rodents and Lagomorphs 1994, 85-117. Elsevier Science, Amsterdam. A.D.M.E. Osterhaus (Ed.).
13. Jonjic Stipan, Bubic Ivan, Krmpotic A. Innate immunity to cytomegalovirus. Cytomegalovirus: Molecular Biology and Immunology 2006, 285-319. Caister Academic Press, Norfolk. M.J. Reddehase (Ed.).
14. Jordan M.C. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect. Immun. 1978, 21(1):275-280.
15. Jutte A., Fatkenheuer G., Hell K., Salzberger B. CMV sinusitis as the initial manifestation of AIDS. HIV Med. 2000, 1(2):123-124.
16. Kubota A., Kubota S., Farrell H.E., Davis-Poynter N., Takei F. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 1999, 191(2):145-151.
17. Kuper C.F., Koornstra P.J., Hameleers D.M., Biewenga J., Spit B.J., Duijvestijn A.M., van Breda Vriesman P.J., Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol. Today 1992, 13(6):219-224.
18. Marks S.C., Upadhyay S., Crane L. Cytomegalovirus sinusitis. A new manifestation of AIDS. Arch. Otolaryngol.-Head Neck Surg. 1996, 122(7):789-791.
19. Muller W.J., Jones C.A., Koelle D.M. Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr. Immunol. Rev. 2010, 6(1):38-55.
20. Nijman J., van Loon A.M., de Vries L.S., Koopman-Esseboom C., Groenendaal F., Uiterwaal C.S., Verboon-Maciolek M.A. Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection. J. Clin. Virol. 2012, 54(2):121-124.
21. Prichard M.N., Penfold M.E., Duke G.M., Spaete R.R., Kemble G.W. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 2001, 11(3):191-200.
22. Prince H.E., Lape-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin. Vaccine Immunol. 2014, 21(10):1377-1384.
23. Shellam G.R., Redwood A.J., Smith L.M., Gorman S. Murine cytomegalovirus and other herpesviruses. The Mouse in Biomedical Research 2007, II, IV:1-48. Academic Press, Waltham. 2 ed.
24. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. 2002, 99(13):8826-8831.
25. Smith L.M., Shellam G.R., Redwood A.J. Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 2006, 352(2):450-465.
26. Smith L.M., McWhorter A.R., Masters L.L., Shellam G.R., Redwood A.J. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 2008, 82(13):6689-6696.
27. Stahl F.R., Heller K., Halle S., Keyser K.A., Busche A., Marquardt A., Wagner K., Boelter J., Bischoff Y., Kremmer E., Arens R., Messerle M., Forster R. Nodular inflammatory foci are sites of T cell priming and control of murine cytomegalovirus infection in the neonatal lung. PLoS Pathog. 2013, 9(12):e1003828.
28. Tan C.S., Frederico B., Stevenson P.G. Herpesvirus delivery to the murine respiratory tract. J. Virol. Methods 2014, 206:105-114.
29. Treuting Piper M., Morton Thomas H. Oral cavity and teeth. Comparative Anatomy and Histology: A Mouse and Human Atlas 2012, 95-110. Academic Press, Waltham. P.M. Treuting, S.M. Dintzis (Eds.).
30. Wejse C., Birkebaek N.H., Nielsen L.P., Andersen H.M. Respiratory tract infections in cytomegalovirus-excreting and nonexcreting infants. Pediatr. Infect. Dis. J. 2001, 20(3):256-259.
31. Zhang S.C., Xiang J., Doorsselaere J.V., Nauwynck H.J. Comparison of the pathogenesis of the highly passaged MCMV Smith strain with that of the low passaged MCMV HaNa1 isolate in BALB/c mice upon oronasal inoculation. Vet. Res. 2015, 46:94.
32. Zuercher A.W., Coffin S.E., Thurnheer M.C., Fundova P., Cebra J.J. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J. Immunol. 2002, 168(4):1796-1803.